Brief: Gland Pharma Q1 Consol Net Profit 2.15 Billion Rupees IBES EST. 2.03 Billion Rupees
05/08/2025 12:15
Aug 5 (Reuters) - Gland Pharma Ltd GLAD.NS: GLAND PHARMA Q1 CONSOL NET PROFIT 2.15 BILLION RUPEES; IBES EST. 2.03 BILLION RUPEES GLAND PHARMA Q1 CONSOL REVENUE FROM OPERATIONS 15.06 BILLION RUPEES; IBES EST. 15.31 BILLION RUPEES Source text: ID:nBSE7mmSGt Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant